Term ended Mar 24, 2025 · High confidence
20-year base term ended Jun 10, 2025
Held by Collegium Pharmaceutical, Inc.
Filed Jun 25, 2010 as application 12/823,628 · Granted May 28, 2013
Base term, 20 years from filing · capped by a resolved terminal disclaimer
Today
Term ended Mar 24, 2025
2005
2026
Clock starts
Jun 10, 2005
Jun 10, 2005
Term ended
Mar 24, 2025
Mar 24, 2025
Granted
May 28, 2013
May 28, 2013
base term
after the term ends
fee events
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 7,771,707.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
36
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. All three maintenance fees were paid, so no fee lapse ended it. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 10, 2005, when application 11/149,867, the earliest non-provisional in its chain, was filed (this one was filed Jun 25, 2010) | Jun 10, 2025 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,771,707) | capped to Mar 24, 2025 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Mar 24, 2025 | High confidence |
Partial family
| US 7,399,488 | Term ended Mar 2025 | Mar 2025 |
| US 7,771,707 | In force Oct 2028 | Oct 2028 |
| Application 12/112,937 | Abandoned not computed | not computed |
| Application 12/112,993 | Abandoned not computed | not computed |
| US 8,557,291 | Term ended Mar 2025 | Mar 2025 |
| US 8,449,909 | this patent Mar 2025 | Mar 2025 |
| US 8,840,928 | Term ended Jul 2023 | Jul 2023 |
| US 9,044,398 | Term ended Jul 2023 | Jul 2023 |
8 of 36 applications in this family shown, earliest filings first. Partial: 5 of the 36 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 30, 2010 Reel 24615, frame 677 | Hirsh, Jane C.; Fleming, Alison B.; Rariy, Roman V.; Klibanov, Alexander M. | Collegium Pharmaceutical, Inc. | Assignment of Assignor's Interest |
| Feb 13, 2020 Reel 51817, frame 583 | Collegium Pharmaceutical, Inc. | Biopharma Credit PLC | Security Interest |
| Mar 22, 2022 Reel 59474, frame 526 | Collegium Pharmaceutical, Inc. | Biopharma Credit PLC | Amended and Restated Patent Security Agreement |
| Dec 23, 2025 Reel 73308, frame 342 | Biopharma Credit PLC | Collegium Pharmaceutical, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 7,771,707.
Citations
55
later US patents cite this one
That is top 10% of utility patents granted in 2013 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.